Could Probiodrug Represent A New Era Of Alzheimer's R&D Progress?
Executive Summary
Probiodrug believes it can bring success to an Alzheimer's research community that has been hard hit by clinical failures in the last few years – but the company will need a partner or cash influx to take its first-in-class drug through late-stage trials.